Temporal Relationships Between Circulating Levels of CC and CXC Chemokines and Developing Atherosclerosis in Apolipoprotein E*3 Leiden Mice
Por um escritor misterioso
Descrição
References - The Design and Statistical Analysis of Animal Experiments
Chemokines as Therapeutic Targets in Cardiovascular Disease
Epigenetic Mechanisms in Vascular Inflammation: Modulation of Endothelial Adhesion Molecules and Endothelium-Leukocyte Adhesion
CC Chemokine Receptors and Chronic Inflammation—Therapeutic Opportunities and Pharmacological Challenges
Increased C-C Chemokine Receptor 2 Gene Expression in Monocytes of Severe Obstructive Sleep Apnea Patients and under Intermittent Hypoxia
PDF) Circulating levels of the chemokines JE and KC in female C3H apolipoprotein-E-deficient and C57BL apolipoprotein-E-deficient mice as potential markers of atherosclerosis development
IJMS, Free Full-Text
Gregory BENSON, Director, BSc, PhD, Drug Development Services
Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system - ScienceDirect
PDF) Differential Influence of Chemokine Receptors CCR2 and CXCR3 in Development of Atherosclerosis In Vivo
Monocytic C-C chemokine receptor 5 expression increases in in vitro intermittent hypoxia condition and in severe obstructive sleep apnea patients
de
por adulto (o preço varia de acordo com o tamanho do grupo)
